Key Highlights
- Ginkgo Bioworks releases first proprietary protein LLM, trained on exclusive datasets.
- Collaboration with Google Cloud enables AI-driven drug discovery tools.
- Open API allows researchers to access Ginkgo’s machine learning models affordably.
- Chris Sakalosky, Google Cloud praises Ginkgo for democratizing AI tools in life sciences.
Source: Business Wire
Notable Quotes
- “We believe that the low cost for tokens and our customer-friendly terms will allow users to build innovative tools and applications.” — Jason Kelly, CEO at Ginkgo Bioworks
- “Ginkgo’s new protein LLM and open API mark a major step forward in making advanced AI tools accessible for drug discovery.” — Chris Sakalosky, VP of Strategic Industries at Google Cloud
- “Our API comes with competitive pricing and a free tier, empowering users to experiment without high fees.” — Ankit Gupta, General Manager at Ginkgo AI
SoHC's Take
This launch marks a significant milestone in the biotech industry, merging cutting-edge AI with biological research. By partnering with Google Cloud, Ginkgo Bioworks is unlocking new potential for drug discovery and biotechnology innovation. The release of a proprietary protein LLM and an open API demonstrates Ginkgo’s commitment to making advanced research tools more accessible and affordable, a game-changer for pharmaceutical and biotech industries looking to streamline and scale their R&D efforts. The user-friendly pricing model further ensures that even smaller entities can benefit from these sophisticated technologies.
Heading
Key Highlights CalmWave closes a $5.25M financing round led by Third Prime with contributions from Catalyst by Wellstar, Silver Circle, and ...
Key Highlights Alice Koehler appointed Managing Director of OMRON Healthcare North America. Koehler brings 25+ years of global experience in ...
Key Highlights Koda Health introduces Kidney Action Planning to support Chronic Kidney Disease (CKD) management with cutting-edge tools. Features include gamified patient ...
Key Highlights Northwell Health’s Aging Revolution Summit will take place virtually and in-person in NYC on December 3, 2024. Key themes: Therapeutics, ...
Key Highlights $5M Series A funding led by Empactful Capital to fuel growth and innovation. Investment will support product development, strategic accounts, and new market ...
Key Highlights New Lantern raises $19M Series A funding, led by Benchmark, totaling $23M raised to date. Platform automates 25% of ...
